87
65
Growth Score
1 pts
Heat Score
10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
675306
Vaxira is a therapeutic vaccine for the treatment of non-small cell lung cancer
About the Company
Vaxira® is an immunotherapeutic agent whose formula consists of the anti-idiotype monoclonal antibody Racotumomab and aluminum hydroxide (HA), a widely used adjuvant. HA improves the production of antibodies, but it is neither immunogenic nor a hapten. It behaves like "depot" at the injection site, from which the antigen is released
slowly, and induces the formation of granulomas that attract immunocompetent cells, such as plasma cells that produce antibodies. HA can directly stimulate monocytes to produce proinflammatory cytokines that can activate T cells and possibly stimulate B cell responses.
